LSCDS #ScienceNews and #Innovation

Today, in our weekly LSCDS feature #ScienceNews,  we would like to cover this editorial from FiercePharma: “No means no: Global pharma group bans any and all gifts to doctors”.

In industry, the spotlight is on Pfizer as the New York pharma giant eyes a controversial buyout deal of the cardiovascular player Amarin.

Lastly, a victorious win in the long battle against cancer as Merck & Co. announced the sizable survival benefit of its’ immuno-oncology star, Keytruda, in esophageal cancer.

By |2019-01-16T11:58:52+00:00January 16th, 2019|Bassem Toeama, ScienceNews&Innovation|0 Comments

Leave A Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.